Zoladex LA 10.8mg Depot Safesystem 10.8mg Syringe POM x1

Implant, in pre-filled syringe.

Therapeutic indications:
Zoladex is indicated:
• In the treatment of metastatic prostate cancer where Zoladex has demonstrated comparable survival benefits to surgical castrations
• In the treatment of locally advanced prostate cancer, as an alternative to surgical castration where Zoladex has demonstrated comparable survival benefits to an anti-androgen
• As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival and overall surviva
• As neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival
• As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression where Zoladex has demonstrated improved disease-free survival (see section 5.1)

Features

Nature and contents of container
• Zoladex LA is supplied as a single dose SafeSystem™ syringe applicator with a protective sleeve in a sealed pouch which contains a desiccant.

Special precautions for storage
• Do not store above 25°C.

Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.1567.pdf